Actualités p53.html
Study reveals how mutant p53 protein converts other proteins into cancer drivers
Mon, 16 Sep 2024 09:11:04 GMT
Research from the Federal University of Rio de Janeiro (UFRJ) and the National Institute of Science and Technology for Structural Biology and Bioimaging (INBEB) in Brazil has uncovered a critical ...
What Causes Cervical Cancer?
Wed, 11 Sep 2024 02:00:00 GMT
Learn about cervical cancer, its main cause (HPV), risk factors, and the importance of screenings and vaccinations for prevention and early detection.
Mom, 40, and son, 11, diagnosed with cancer months apart due to rare genetic syndrome
Fri, 06 Sep 2024 16:19:00 GMT
Sarah and Jack Holm have Li-Fraumeni syndrome, a genetic condition that increases cancer diagnoses. Want to raise awareness of condition to help others.
OREO Coca-Cola Cookies: Newest ‘besties’ for a limited time only
Sat, 14 Sep 2024 03:30:00 GMT
OREO Philippines announced the launch of the limited-edition OREO Coca-Cola cookies, arriving this month in major nationwide supermarkets and select retailers. In a world where true and genuine ...
Fever drives enhanced activity and mitochondrial damage in a subset of T cells, study finds
Fri, 20 Sep 2024 11:00:01 GMT
Fever temperatures rev up immune cell metabolism, proliferation and activity, but they also—in a particular subset of T cells—cause mitochondrial stress, DNA damage and cell death, Vanderbilt ...
Elicio Therapeutics Reports Inducement Grants
Tue, 17 Sep 2024 05:31:00 GMT
Inc. (Nasdaq: ELTX, “” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that on September 16, 2024, ...
Datopotamab deruxtecan showed median overall survival of 14.6 months in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial
Mon, 09 Sep 2024 10:50:00 GMT
Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab ...
Canary Speech Receives Patent for Paired Neural Networks Technology
Tue, 10 Sep 2024 10:38:00 GMT
Canary Speech Inc., the leading AI-powered voice biomarker technology company, is proud to announce the award of a new patent for its innovative paired neural networks system, officially titled ...
Repare Therapeutics Announces New Data Underscoring Need for Additional Treatment Solutions for Patients with Metastatic Gynecologic Cancers
Mon, 23 Sep 2024 04:05:00 GMT
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, presented new data on Friday highlighting the impact of alterations in FBXW7, ...
House committee cuts OVP budget, redirects funds to DSWD, DOH
Wed, 11 Sep 2024 22:12:00 GMT
Marikina Rep. Stella Quimbo, ssaid they are planning to realign an estimated P1-billion worth of public funds from the social services budget of the OVP to DSWD and DOH.
Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines
Fri, 13 Sep 2024 05:29:00 GMT
Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced upcoming ...
Fever drives enhanced activity, mitochondrial damage in immune cells: Study
Sun, 22 Sep 2024 20:11:00 GMT
Fever increases immune cell metabolism, proliferation, and activity, but it also causes mitochondrial stress, DNA damage, and cell death in a specific subgroup of T cells, according to Vanderbilt ...